The Bolton Treo Endograft: A Single-Center Preliminary Experience

Enrico Maria Maria Marone, Luigi F. Rinaldi, Maurizio Lovotti, Piernicola Palmieri, Angelo Argenteri

Research output: Contribution to journalArticle

Abstract

Background: Endovascular repair is currently the most frequently used treatment of abdominal aortic aneurysms, but its feasibility and success highly depend on the characteristics and the correct choice of the endograft to be used. Bolton Treo is one of the most popular endografts of newer generation which have been launched in the past few years, and this study aims to analyze the preliminary outcomes (8 months in average) of a single-center experience with this device. Methods: Thirty-seven consecutive abdominal aortic aneurysms, treated with Treo between June 2016 and December 2017, were followed up every 3, 6, and 12 months, and any kind of endograft-related complications was recorded. Results: Technical success was 100%, and no perioperative death (within 30 days) was recorded. Over a mean follow-up period of 8 months, the overall reintervention rate was 5.4% (2 cases, for a type Ia endoleak and an iliac branch thrombosis), for those performed by endovascular techniques. Two type II endoleaks, not worthy of treatment, were also observed. No procedure-related mortality, endograft thrombosis, or rupture was observed. Conclusions: Over the short term, Treo demonstrated high effectiveness in treating abdominal aortic aneurysms both in elective and urgent settings, within and outside the indications for use. Outcomes over long term are still needed to validate these results.

Original languageEnglish
JournalAnnals of Vascular Surgery
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Abdominal Aortic Aneurysm
Endoleak
Thrombosis
Endovascular Procedures
Rupture
Equipment and Supplies
Mortality

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

The Bolton Treo Endograft : A Single-Center Preliminary Experience. / Marone, Enrico Maria Maria; Rinaldi, Luigi F.; Lovotti, Maurizio; Palmieri, Piernicola; Argenteri, Angelo.

In: Annals of Vascular Surgery, 01.01.2018.

Research output: Contribution to journalArticle

Marone, Enrico Maria Maria ; Rinaldi, Luigi F. ; Lovotti, Maurizio ; Palmieri, Piernicola ; Argenteri, Angelo. / The Bolton Treo Endograft : A Single-Center Preliminary Experience. In: Annals of Vascular Surgery. 2018.
@article{c24bc13fe2d242d3b262ac3411cdd108,
title = "The Bolton Treo Endograft: A Single-Center Preliminary Experience",
abstract = "Background: Endovascular repair is currently the most frequently used treatment of abdominal aortic aneurysms, but its feasibility and success highly depend on the characteristics and the correct choice of the endograft to be used. Bolton Treo is one of the most popular endografts of newer generation which have been launched in the past few years, and this study aims to analyze the preliminary outcomes (8 months in average) of a single-center experience with this device. Methods: Thirty-seven consecutive abdominal aortic aneurysms, treated with Treo between June 2016 and December 2017, were followed up every 3, 6, and 12 months, and any kind of endograft-related complications was recorded. Results: Technical success was 100{\%}, and no perioperative death (within 30 days) was recorded. Over a mean follow-up period of 8 months, the overall reintervention rate was 5.4{\%} (2 cases, for a type Ia endoleak and an iliac branch thrombosis), for those performed by endovascular techniques. Two type II endoleaks, not worthy of treatment, were also observed. No procedure-related mortality, endograft thrombosis, or rupture was observed. Conclusions: Over the short term, Treo demonstrated high effectiveness in treating abdominal aortic aneurysms both in elective and urgent settings, within and outside the indications for use. Outcomes over long term are still needed to validate these results.",
author = "Marone, {Enrico Maria Maria} and Rinaldi, {Luigi F.} and Maurizio Lovotti and Piernicola Palmieri and Angelo Argenteri",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.avsg.2018.08.080",
language = "English",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - The Bolton Treo Endograft

T2 - A Single-Center Preliminary Experience

AU - Marone, Enrico Maria Maria

AU - Rinaldi, Luigi F.

AU - Lovotti, Maurizio

AU - Palmieri, Piernicola

AU - Argenteri, Angelo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Endovascular repair is currently the most frequently used treatment of abdominal aortic aneurysms, but its feasibility and success highly depend on the characteristics and the correct choice of the endograft to be used. Bolton Treo is one of the most popular endografts of newer generation which have been launched in the past few years, and this study aims to analyze the preliminary outcomes (8 months in average) of a single-center experience with this device. Methods: Thirty-seven consecutive abdominal aortic aneurysms, treated with Treo between June 2016 and December 2017, were followed up every 3, 6, and 12 months, and any kind of endograft-related complications was recorded. Results: Technical success was 100%, and no perioperative death (within 30 days) was recorded. Over a mean follow-up period of 8 months, the overall reintervention rate was 5.4% (2 cases, for a type Ia endoleak and an iliac branch thrombosis), for those performed by endovascular techniques. Two type II endoleaks, not worthy of treatment, were also observed. No procedure-related mortality, endograft thrombosis, or rupture was observed. Conclusions: Over the short term, Treo demonstrated high effectiveness in treating abdominal aortic aneurysms both in elective and urgent settings, within and outside the indications for use. Outcomes over long term are still needed to validate these results.

AB - Background: Endovascular repair is currently the most frequently used treatment of abdominal aortic aneurysms, but its feasibility and success highly depend on the characteristics and the correct choice of the endograft to be used. Bolton Treo is one of the most popular endografts of newer generation which have been launched in the past few years, and this study aims to analyze the preliminary outcomes (8 months in average) of a single-center experience with this device. Methods: Thirty-seven consecutive abdominal aortic aneurysms, treated with Treo between June 2016 and December 2017, were followed up every 3, 6, and 12 months, and any kind of endograft-related complications was recorded. Results: Technical success was 100%, and no perioperative death (within 30 days) was recorded. Over a mean follow-up period of 8 months, the overall reintervention rate was 5.4% (2 cases, for a type Ia endoleak and an iliac branch thrombosis), for those performed by endovascular techniques. Two type II endoleaks, not worthy of treatment, were also observed. No procedure-related mortality, endograft thrombosis, or rupture was observed. Conclusions: Over the short term, Treo demonstrated high effectiveness in treating abdominal aortic aneurysms both in elective and urgent settings, within and outside the indications for use. Outcomes over long term are still needed to validate these results.

UR - http://www.scopus.com/inward/record.url?scp=85056715104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056715104&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2018.08.080

DO - 10.1016/j.avsg.2018.08.080

M3 - Article

AN - SCOPUS:85056715104

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

ER -